Other Collaboration Sample Clauses

Other Collaboration. SES Americom agrees, at Customer's request, to collaborate on the design and deployment of Customer's next-generation Ka-band satellite system, with possible operational or financing services to be provided by SES Americom. Any agreements resulting from such collaboration are subject to mutual agreement of the parties, each acting in its sole discretion.
AutoNDA by SimpleDocs
Other Collaboration. During the term of the Program, and in ------------------- the event that Albany desires to enter into a collaboration or other arrangement with a Third Party in the area of Combinatorial Technology research that would not utilize Lilly Licensed Technology or Program Technology, Albany shall inform the Program Chairs. The Program Chairs may approve or disapprove such proposed collaboration or other arrangement. In the event the Program Chairs disapprove, Albany shall not enter into such collaboration or other arrangement. In the event that the Program Chairs are unable to agree, such question shall be referred to the Executive Director of Lilly's Research Technologies for resolution. If such a collaboration or other arrangement is approved, any such collaboration or other arrangement conducted at Albany facilities shall be conducted in facilities that are separate from those facilities used to conduct the Program.
Other Collaboration. This agreement does not exclude a collaboration of either of the contractual partners with third parties outside of the contractual subject matter or relating to the subject matter of this agreement.
Other Collaboration. The Parties acknowledge and agree that the foregoing Operating Arrangements are not intended to be exhaustive and each Party and its Affiliates may engage with the other Party and its Affiliates with respect to other collaborative measures as may be mutually agreed from time to time. As part of such other collaboration activities Beyond shall use commercially reasonable efforts to introduce Xxxxxxxx’x to Beyond’s product and business vendors. Upon Xxxxxxxx’x request, Beyond will consider in good faith and discuss with Xxxxxxxx’x opportunities for further collaboration between the Parties with respect to other e-commerce retail operations or brands owned or controlled from Beyond and not included in the Operating Arrangements at such time. In addition, from and after the Effective Date and during the Term, upon request by Beyond, Xxxxxxxx’x shall make available certain merchandising services, including product sourcing, selection, supply chain and inventory management for the support of BBB E-Commerce Channel, on terms and conditions, including compensation and reimbursement, to be mutually agreed upon by the Parties in good faith upon such request from Beyond, which terms shall be memorialized by amendment to this Agreement or any exhibit hereto.
Other Collaboration i) As desired by the Parties, USAID and Peace Corps may also collaborate on other sector, program, national or regional initiatives that focus on building the capacity of local communities to implement sustainable development projects. For each of these specific collaborations, the parties will develop the goals, objectives and desired results, and indicate how each initiative will respond to one or more of the Intermediate Results for the Program. ii) On occasion, Participating Agency posts may request support to conduct country-level evaluations and/or impact assessments of their performance under this Agreement. These evaluations will assess the Program’s performance in strengthening the capabilities of local communities and community organizations to carry out low-cost, sustainable, grassroots development activities. Any such evaluation will be in addition to the monitoring and evaluation requirements described in Section F, below and the regular sharing of information on Program performance with USAID Missions in each Participating Agency post.
Other Collaboration. On the basis of equity collaboration as mentioned above, the Parties will engage in comprehensive communication and collaboration in the development of photovoltaic power station and other related areas of photovoltaic industry such as management, technology, research and development, etc. The Framework Agreement is an indication of the Parties’ intention to collaborate and the purpose, principle and content of collaboration as set out under the Framework Agreement do not impose any legal or binding obligations on either Party. The Parties will separately negotiate and enter into detailed and legally-binding definitive agreements upon: (1) Completion of the due diligence process to the satisfaction of the Parties; (2) Consideration for the proposed transactions having been confirmed after the target companies are audited and valued by third party institutions; (3) Details of the proposed collaboration having been approved by authorised institutions of each Party; and (4) All matters relating to the proposed collaboration and the terms of all definitive agreements having been agreed by the Parties. Under the Framework Agreement, the Parties agreed to an exclusivity period of 6 months, during which neither Party may discuss, negotiate or enter into any agreement or arrangement with any third party on transactions that are similar to or have the potential of replacing the transactions contemplated under the Framework Agreement. The Company will comply with all relevant disclosure obligations under Chapter 14 and Chapter 14A of the Listing Rules when the definitive agreements are subsequently entered into. Hong Kong, 11 August 2017
Other Collaboration. (a) Except as described in Paragraph 6(b), Shionogi shall have no obligation to provide assistance to InterMune in the Pirfenidone regulatory approval process within any of InterMune’s Respective Territories. (b) Each Party agrees that, if so requested, it will cooperate in good faith and use its reasonable best efforts to obtain and share with the other Party Certificates of Suitability relating to Product as necessary in order to assist such other Party’s marketing approval efforts for Product in its Respective Territories. Cooperation with respect to obtaining Certificates of Suitability, or submission of Certificates of Suitability to any regulatory authority in connection with an NDA, shall not trigger any royalty obligations.
AutoNDA by SimpleDocs
Other Collaboration. In addition to our continuing work with XXXX, the University has submitted a Statement of Intent as one of the co-lead sponsors to develop a University Technical College in Nottingham. The UTC will provide high quality technical and vocational education and training to 14-19 year-olds. Local, regional and national employers will contribute to the design, development and delivery of the curriculum. The University’s contribution will harness the significant expertise and specialist facilities of our Faculty of Engineering and Centre for Sustainable Energy Technologies. The University will also be working with Broxtowe Borough Council in developing the XX Xxxxxxxx Heritage Centre, Durban House, and safeguarding its future. Durban House attracts visitors from all over the world, but the focus of current proposals is on supporting the University’s outreach activities with local schools in an area of social deprivation. Other joint opportunities include summer schools, creative writing links, short courses, lectures, events and exhibitions using material from the University archive. Durban House may develop into one of the Nottingham Potential centres.
Other Collaboration. For mutual benefits, the two parties might from time to time explore collaboration in other areas, including conducting joint research on issues of mutual interests.

Related to Other Collaboration

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Joint Patent Rights If not already established under the Research Collaboration Agreement, prior to either Party filing any Patent Right disclosing Joint Program Technology or Joint Probody Platform Improvements, the Parties shall establish a patent committee (the “Patent Committee”) comprised of at least one (1) representative of each Party for the purpose of facilitating the preparation, filing, prosecution, maintenance and defense of Joint Patent Rights. As agreed upon by the Parties, meetings of the Patent Committee may be face-to-face or may be conducted by teleconferences or videoconferences, from time to time as needed. The Patent Committee will be the forum through which the Parties coordinate their respective obligations to each other described in Sections 5.2.2 and 5.2.3 hereof and in this Section. In the event the Parties conceive or generate any Joint Program Technology or Joint Probody Platform Improvements, the Parties shall promptly meet to discuss and determine, based on mutual consent, whether to seek patent protection thereon, which Party will control filing, prosecution and maintenance of such patents and how to pay for the filing, prosecution and maintenance of such patents. It is presumed that ImmunoGen will control filing, prosecution and maintenance of Joint Patent Rights claiming Joint Program Technology or Joint Conjugation Probody Platform Improvements, and that CytomX will control filing, prosecution and maintenance of Joint Patent Rights claiming Joint Unconjugated Probody Platform Improvements. Neither Party will file any Joint Patent Right without the prior written consent of the other Party, which consent shall not be unreasonably withheld, conditioned or delayed. The Party controlling filing and prosecution of any such Joint Patent Right (a) shall keep the other Party informed regarding each Patent Right, (b) shall consider in good faith any recommendations made by the other Party in regard to the filing, prosecution or maintenance of any such Patent Right and (c) shall not unreasonably refuse to incorporate any recommendations made by the other Party in regard to such filing, prosecution or maintenance.

  • Commercial Activities Neither Contractor nor its employees shall establish any commercial activity or issue concessions or permits of any kind to Third Parties for establishing commercial activities on the Site or any other lands owned or controlled by Owner.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Development of the Property Except as modified by this Agreement, the Development and the Property will be developed in accordance with all applicable local, state, and federal regulations, including but not limited to the City’s ordinances and the zoning regulations applicable to the Property, and such amendments to City ordinances and regulations that that may be applied to the Development and the Property under Chapter 245, Texas Local Government Code, and good engineering practices (the “Applicable Regulations”). If there is a conflict between the Applicable Regulations and the Development Standards, the Development Standards shall control.

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!